APA

Hitz F., Martinelli G., Zucca E., von Moos R., Mingrone W., Simcock M., Peterson J., Cogliatti S. B., Bertoni F., Zimmermann D. R. & Ghielmini M. (20091013). A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03. : Hematological oncology.

Chicago

Hitz F, Martinelli G, Zucca E, von Moos R, Mingrone W, Simcock M, Peterson J, Cogliatti S B, Bertoni F, Zimmermann D R and Ghielmini M. 20091013. A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03. : Hematological oncology.

Harvard

Hitz F., Martinelli G., Zucca E., von Moos R., Mingrone W., Simcock M., Peterson J., Cogliatti S. B., Bertoni F., Zimmermann D. R. and Ghielmini M. (20091013). A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03. : Hematological oncology.

MLA

Hitz F, Martinelli G, Zucca E, von Moos R, Mingrone W, Simcock M, Peterson J, Cogliatti S B, Bertoni F, Zimmermann D R and Ghielmini M. A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03. : Hematological oncology. 20091013.